title: Diabetes resolution following discontinuation of a second-generation antipsychotic.
authors.affiliation: Department of Psychiatry, Miller School of Medicine, University of Miami, Miami, FL, USA. MStrassnig@med.miami.edu
authors.forename: Martin
authors.initials: M
authors.lastname: Strassnig
authors.forename: Jon
authors.initials: J
authors.lastname: Awerbuck
authors.forename: Rohan
authors.initials: R
authors.lastname: Ganguli
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D000077152:Olanzapine; D018967:Risperidone / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy*; D028761:Withholding Treatment
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine